62 related articles for article (PubMed ID: 36044723)
1. Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
Davis CS; Faino AV; Onchiri F; Gibson RL; Merjaneh L; Ramsey BW; Rosenfeld M; Cogen JD
Ann Am Thorac Soc; 2023 Jan; 20(1):75-82. PubMed ID: 36044723
[No Abstract] [Full Text] [Related]
2. Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis.
McElvaney OJ; Heltshe SL; Odem-Davis K; West NE; Sanders DB; Fogarty B; VanDevanter DR; Flume PA; Goss CH
Ann Am Thorac Soc; 2024 May; 21(5):716-726. PubMed ID: 38096105
[No Abstract] [Full Text] [Related]
3. The Clinical Association between
O'Dea AL; Feng R; Glaser LJ; Kubrak C; Rubenstein RC; Dorgan DJ; Hadjiliadis D; Kawut SM; Hong G
Ann Am Thorac Soc; 2023 Jul; 20(7):984-992. PubMed ID: 36800434
[No Abstract] [Full Text] [Related]
4. Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.
Thornton CS; Caverly LJ; Kalikin LM; Carmody LA; McClellan S; LeBar W; Sanders DB; West NE; Goss CH; Flume PA; Heltshe SL; VanDevanter DR; LiPuma JJ
Ann Am Thorac Soc; 2024 Apr; 21(4):595-603. PubMed ID: 37963297
[No Abstract] [Full Text] [Related]
5. Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations.
Heltshe SL; Russell R; VanDevanter DR; Sanders DB
J Cyst Fibros; 2023 Sep; 22(5):864-867. PubMed ID: 36803635
[TBL] [Abstract][Full Text] [Related]
6. Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative.
List R; Solomon G; Bichl S; Horton BJ; Shen S; Corcoran B; Sadeghi H; Britto MT; Ren C; Albon D;
BMJ Open Qual; 2023 Dec; 12(4):. PubMed ID: 38154821
[TBL] [Abstract][Full Text] [Related]
7. Clinical features associated with pulmonary exacerbation diagnosis in infants and young children with cystic fibrosis.
Corcoran A; Faig W; Ren CL
Pediatr Pulmonol; 2024 Apr; 59(4):874-879. PubMed ID: 38131505
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis.
Blanchard AC; Shaw M; Ratjen F; Tullis E; Daneman N; Waters V
J Cyst Fibros; 2023 Sep; 22(5):880-883. PubMed ID: 37474423
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis.
Hahn A; Burrell A; Chaney H; Sami I; Koumbourlis AC; Freishtat RJ; Crandall KA; Zemanick ET
Sci Rep; 2023 Jan; 13(1):1217. PubMed ID: 36681756
[TBL] [Abstract][Full Text] [Related]
10. A Pilot Randomized Clinical Trial of Pediatric Cystic Fibrosis Pulmonary Exacerbations Treatment Strategies.
Sanders DB; Bartz TM; Zemanick ET; Hoppe JE; Hinckley Stukovsky KD; Cogen JD; Bendy L; McNamara S; Enright E; Kime NA; Kronmal RA; Edwards TC; Morgan WJ; Rosenfeld M
Ann Am Thorac Soc; 2023 Dec; 20(12):1769-1776. PubMed ID: 37683122
[No Abstract] [Full Text] [Related]
11. Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic.
Patel S; Thompson MD; Slaven JE; Sanders DB; Ren CL
Pediatr Pulmonol; 2021 May; 56(5):1271-1273. PubMed ID: 33434352
[TBL] [Abstract][Full Text] [Related]
12. Airway clearance therapy in the school environment: Retrospective analysis of a cohort of pediatric patients with cystic fibrosis.
Byrwa DJ; Perez GF; Roach CM; Prentice S; Goetz DM
J Cyst Fibros; 2023 Sep; 22(5):811-815. PubMed ID: 36702656
[TBL] [Abstract][Full Text] [Related]
13. Acute respiratory failure due to pulmonary exacerbation in children with cystic fibrosis admitted in a pediatric intensive care unit: outcomes and factors associated with mortality.
Drummond D; Roy C; Cornet M; Bucher J; Boussaud V; Pimpec-Barthes FL; Pontailler M; Raisky O; Lopez V; Barbanti C; Guillemain R; Renolleau S; Grimaud M; Oualha M; de Saint Blanquat L; Sermet-Gaudelus I
Respir Res; 2024 Apr; 25(1):190. PubMed ID: 38685088
[TBL] [Abstract][Full Text] [Related]
14. Lung Function Decline in Cystic Fibrosis: Impact of Data Availability and Modeling Strategies on Clinical Interpretations.
Szczesniak R; Andrinopoulou ER; Su W; Afonso PM; Burgel PR; Cromwell E; Gecili E; Ghulam E; Goss CH; Mayer-Hamblett N; Keogh RH; Liou TG; Marshall B; Morgan WJ; Ostrenga JS; Pasta DJ; Stanojevic S; Wainwright C; Zhou GC; Fernandez G; Fink AK; Schechter MS
Ann Am Thorac Soc; 2023 Jul; 20(7):958-968. PubMed ID: 36884219
[No Abstract] [Full Text] [Related]
15. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
Widder S; Carmody L; Opron K; Kalikin L; Caverly L; LiPuma J
Res Sq; 2024 Mar; ():. PubMed ID: 38562856
[TBL] [Abstract][Full Text] [Related]
16. Impact of age at ivacaftor initiation on pulmonary outcomes among people with cystic fibrosis.
Merlo CA; McGarry LJ; Thorat T; Nguyen C; DerSarkissian M; Muthukumar A; Healy J; Brookhart MA; Rubin JL
Thorax; 2024 May; ():. PubMed ID: 38719441
[TBL] [Abstract][Full Text] [Related]
17. Home-spirometry exacerbation profiles in children with cystic fibrosis.
Bouteleux B; Beaufils F; Fayon M; Bui S
Pediatr Pulmonol; 2024 Mar; 59(3):552-561. PubMed ID: 38014613
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and Safety of Outpatient Parenteral Antimicrobial Therapy in Select Children with Cystic Fibrosis.
Com G; Agarwal A; Bai S; Hu Z; Goode G; McCarty H; Berlinski A
Pediatr Allergy Immunol Pulmonol; 2019 Dec; 32(4):149-154. PubMed ID: 32140285
[No Abstract] [Full Text] [Related]
19. Factors influencing treatment response of pulmonary exacerbation in children with cystic fibrosis.
Singh J; Robinson P; Pandit C; Kennedy B; Weldon B; Bailey B; John M; Fitzgerald D; Selvadurai H
Minerva Pediatr (Torino); 2024 Apr; 76(2):245-252. PubMed ID: 38015431
[TBL] [Abstract][Full Text] [Related]
20. Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes.
Thornton CS; Magaret AS; Carmody LA; Kalikin LM; Simon RH; LiPuma JJ; Caverly LJ
J Cyst Fibros; 2023 May; ():. PubMed ID: 37244842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
